Comparison of prasugrel and clopidogrel in patients with acute coronary syndrome undergoing percutaneous coronary intervention

Antiplatelet agents are the cornerstone of treatment for patients with acute coronary syndrome (ACS) undergoing percutaneous coronary intervention (PCI). Clopidogrel, when added to aspirin, has demonstrated considerable success at reducing thrombotic complications of ACS and/or PCI compared to aspir...

Descripción completa

Detalles Bibliográficos
Autores principales: Norgard, Nicholas B, Abu-Fadel, Mazen
Formato: Texto
Lenguaje:English
Publicado: Dove Medical Press 2009
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2773746/
https://www.ncbi.nlm.nih.gov/pubmed/19898643

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2773746/
https://www.ncbi.nlm.nih.gov/pubmed/19898643

Ejemplares similares